For instance, fibronectin -a key structural component of the ECM has been heavily implicated in the process of tumour development, with reports linking elevated fibronectin expression in breast cancer stroma with tumour aggressiveness and poorer prognosis [11,12]. Here, FN1 is linked to breast carcinoma.